help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soltani, M. H.
Right arrow Articles by Setaluri, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soltani, M. H.
Right arrow Articles by Setaluri, V.
(American Journal of Pathology. 2005;166:1841-1850.)
© 2005 American Society for Investigative Pathology

Microtubule-Associated Protein 2, a Marker of Neuronal Differentiation, Induces Mitotic Defects, Inhibits Growth of Melanoma Cells, and Predicts Metastatic Potential of Cutaneous Melanoma

Mohammad H. Soltani*, Rita Pichardo{dagger}, Ziqui Song{ddagger}, Namrata Sangha{ddagger}, Fabian Camacho§, Kapaettu Satyamoorthy, Omar P. Sangueza{dagger} and Vijayasaradhi Setaluri*{ddagger}

From the Departments of Cancer Biology,* Pathology,{dagger} Dermatology,{ddagger} and Public Health Sciences,§ Wake Forest University School of Medicine, Winston-Salem, North Carolina; and the Wistar Institute, Philadelphia, Pennsylvania

Dynamic instability of microtubules is critical for mitotic spindle assembly and disassembly during cell division, especially in rapidly dividing tumor cells. Microtubule-associated proteins (MAPs) are a family of proteins that influence this property. We showed previously that MAP2, a neuron-specific protein that stabilizes microtubules in the dendrites of postmitotic neurons, is induced in primary cutaneous melanoma but is absent in metastatic melanomas. We proposed that induction of a microtubule-stabilizing protein in primary melanoma could disrupt the dynamic instability of microtubules, inhibit cell division and prevent or delay tumor progression. Here we show, by Kaplan-Meier survival and multivariate Cox regression analysis, that patients diagnosed with MAP2+ primary melanomas have significantly better metastatic disease-free survival than those with MAP2– disease. Investigation of the mechanisms that underlie the effect of MAP2 on melanoma progression showed that MAP2 expression in metastatic melanoma cell lines leads to microtubule stabilization, cell cycle arrest in G2-M phase and growth inhibition. Disruption of microtubule dynamics by MAP2 resulted in multipolar mitotic spindles, defects in cytokinesis and accumulation of cells with large nuclei, similar to those seen in vivo in MAP2+ primary melanomas cells. These data suggest that ectopic activation of a neuronal differentiation gene in melanoma during early tumor progression inhibits cell division and correlates with inhibition or delay of metastasis.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
J. A. Bauer, A. B. Chakravarthy, J. M. Rosenbluth, D. Mi, E. H. Seeley, N. De Matos Granja-Ingram, M. G. Olivares, M. C. Kelley, I. A. Mayer, I. M. Meszoely, et al.
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation
Clin. Cancer Res., January 15, 2010; 16(2): 681 - 690.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Maddodi, K. M. R. Bhat, S. Devi, S.-C. Zhang, and V. Setaluri
Oncogenic BRAFV600E Induces Expression of Neuronal Differentiation Marker MAP2 in Melanoma Cells by Promoter Demethylation and Down-regulation of Transcription Repressor HES1
J. Biol. Chem., January 1, 2010; 285(1): 242 - 254.
[Abstract] [Full Text] [PDF]

Home page
 Am J Clin PatholHome page
T. Gambichler, S. Rotterdam, K. Radkowski, P. Altmeyer, and A. Kreuter
Differential Expression of Microtubule-Associated Protein 2 in Melanocytic Skin Lesions
Am J Clin Pathol, May 1, 2009; 131(5): 710 - 714.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
B. E. G. Rothberg, M. B. Bracken, and D. L. Rimm
Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
J Natl Cancer Inst, April 1, 2009; 101(7): 452 - 474.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
B. Belletti, M. S. Nicoloso, M. Schiappacassi, S. Berton, F. Lovat, K. Wolf, V. Canzonieri, S. D'Andrea, A. Zucchetto, P. Friedl, et al.
Stathmin Activity Influences Sarcoma Cell Shape, Motility, and Metastatic Potential
Mol. Biol. Cell, May 1, 2008; 19(5): 2003 - 2013.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. M.R. Bhat and V. Setaluri
Microtubule-Associated Proteins as Targets in Cancer Chemotherapy
Clin. Cancer Res., May 15, 2007; 13(10): 2849 - 2854.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. Bolos, J. Grego-Bessa, and J. L. de la Pompa
Notch Signaling in Development and Cancer
Endocr. Rev., May 1, 2007; 28(3): 339 - 363.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. M. R. Bhat, N. Maddodi, C. Shashikant, and V. Setaluri
Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling
Nucleic Acids Res., August 11, 2006; 34(13): 3819 - 3832.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.